GLYCOPYRROLATE for Severe asthma with fungal sensitisation: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where GLYCOPYRROLATE was used for Severe asthma with fungal sensitisation.
Most Reported Side Effects for GLYCOPYRROLATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 1,499 | 32.4% | 51 | 593 |
| Asthma | 1,033 | 22.3% | 3 | 533 |
| Cough | 950 | 20.5% | 11 | 255 |
| Wheezing | 782 | 16.9% | 22 | 438 |
| Pneumonia | 454 | 9.8% | 38 | 322 |
| Malaise | 452 | 9.8% | 31 | 165 |
| Drug ineffective | 448 | 9.7% | 8 | 188 |
| Chronic obstructive pulmonary disease | 407 | 8.8% | 30 | 272 |
| Productive cough | 384 | 8.3% | 21 | 178 |
| Chest discomfort | 362 | 7.8% | 4 | 173 |
| Therapeutic product effect incomplete | 341 | 7.4% | 0 | 228 |
| Obstructive airways disorder | 321 | 6.9% | 2 | 179 |
| Condition aggravated | 271 | 5.9% | 7 | 169 |
| Nasal congestion | 267 | 5.8% | 1 | 106 |
| Loss of personal independence in daily activities | 264 | 5.7% | 0 | 164 |
Other Indications for GLYCOPYRROLATE
Product used for unknown indication (1,724)
Chronic obstructive pulmonary disease (861)
Asthma (404)
Emphysema (87)
Bradycardia (68)
Neuromuscular blockade reversal (53)
Hyperhidrosis (52)
Lung disorder (37)
Salivary hypersecretion (33)
Dyspnoea (26)